Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Prevention of Venous Thromboembolism
×
Rivaroxaban
×
Clear all
Filters
3
NCT03055026
2022-03-11
PRO-LAPSII
Fadoi Foundation, Italy
Phase 3
Completed
582 enrolled